Gösterilen 281 - 300 sonuçlar arası kayıtlar. 4,535 sonuç. Aranan kelime '((((notification OR modification) OR justification) OR purification) OR notifications)', Sorgu süresi: 0.16s Sonuçları Daraltın
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286

    Supplementary Material for: Current Knowledge on the Impact of Extracorporeal Blood Purification Devices on Drug Clearance – Systematic Search & Narrative Review Yazar: figshare admin karger (2628495)

    Baskı/Yayın Bilgisi 2025
    “…Introduction Extracorporeal blood purification (EBP) devices are increasingly used in critically ill patients to manage sepsis, hyperinflammatory states, and other life-threatening conditions. …”
  7. 287

    Purification of rAAV vectors using scalable AAVX-based affinity chromatography workflow and assessment of intracerebral delivery routes. Yazar: Claire Verkuyl (22582199)

    Baskı/Yayın Bilgisi 2025
    “…<p><b>(A)</b> Cartoon depicting HYPERFlask and AAVX-based affinity chromatography method for the production and purification of high-titer rAAV9 vector preparations. …”
  8. 288
  9. 289

    One-Step Labeling and Purification: Accelerating FAHFA Detection in Vegetable Oils via Chemoselective Probe-Assisted LC–MS Yazar: Xin-Ze Wu (16624862)

    Baskı/Yayın Bilgisi 2025
    “…The probe enabled single-batch sample pretreatment within 30 min, integrating capture, purification, and signal amplification. Coupled with liquid chromatography–mass spectrometry, the method achieved high sensitivity (LOD: 0.0039–0.033 ng/mL) and enabled quantification of 47 FAHFA isomers in 47 vegetable oil samples, with concentrations ranging from 0.56 to 1.76 × 10<sup>4</sup> ng/g. …”
  10. 290

    Purification of SUMO-PRV peptide AB E10A/E13A/D15A mutant. Yazar: Weiyu Qu (16556638)

    Baskı/Yayın Bilgisi 2025
    “…<p>(A) Nickel column purification of SUMO-PRV peptide AB E10A/E13A/D15A mutant proteins. …”
  11. 291

    Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications Yazar: Olasunkanmi O. Olaoye (10131945)

    Baskı/Yayın Bilgisi 2025
    “…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
  12. 292

    Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications Yazar: Olasunkanmi O. Olaoye (10131945)

    Baskı/Yayın Bilgisi 2025
    “…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
  13. 293
  14. 294

    <b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m Yazar: Jamie Sperger (21646463)

    Baskı/Yayın Bilgisi 2025
    “…The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. …”
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300

    Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual). Yazar: Olivia Hawksworth (19109815)

    Baskı/Yayın Bilgisi 2025
    “…<p>Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual).…”